(Q46466734)
Statements
1 reference
A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: predictive value of early specific toxicities (English)
1 reference
1 reference
Teresa Gamucci
1 reference
Fabrizio Nelli
1 reference
Giovanni Cianci
1 reference
Giulia Grassi
1 reference
Massimo Zeuli
1 reference
Enrico Cortesi
1 reference
Giuliana D'Auria
1 reference
Camillo Francesco Pollera
1 reference
1 July 2008
1 reference
7
1 reference
4
1 reference
273-279
1 reference